BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25882302)

  • 1. Intravenous immunoglobulin and mortality in pneumonia patients with septic shock: an observational nationwide study.
    Tagami T; Matsui H; Fushimi K; Yasunaga H
    Clin Infect Dis; 2015 Aug; 61(3):385-92. PubMed ID: 25882302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin use in septic shock patients after emergency laparotomy.
    Tagami T; Matsui H; Fushimi K; Yasunaga H
    J Infect; 2015 Aug; 71(2):158-66. PubMed ID: 25869539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supplemental dose of antithrombin use in disseminated intravascular coagulation patients after abdominal sepsis.
    Tagami T; Matsui H; Fushimi K; Yasunaga H
    Thromb Haemost; 2015 Aug; 114(3):537-45. PubMed ID: 25948492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic Antibiotics May Improve Outcome in Patients With Severe Burns Requiring Mechanical Ventilation: Propensity Score Analysis of a Japanese Nationwide Database.
    Tagami T; Matsui H; Fushimi K; Yasunaga H
    Clin Infect Dis; 2016 Jan; 62(1):60-6. PubMed ID: 26405146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose immunoglobulin G is not associated with mortality in patients with sepsis and septic shock.
    Iizuka Y; Sanui M; Sasabuchi Y; Lefor AK; Hayakawa M; Saito S; Uchino S; Yamakawa K; Kudo D; Takimoto K; Mayumi T; Azuhata T; Ito F; Yoshihiro S; Hayakawa K; Nakashima T; Ogura T; Noda E; Nakamura Y; Sekine R; Yoshikawa Y; Sekino M; Ueno K; Okuda Y; Watanabe M; Tampo A; Saito N; Kitai Y; Takahashi H; Kobayashi I; Kondo Y; Matsunaga W; Nachi S; Miike T; Takahashi H; Takauji S; Umakoshi K; Todaka T; Kodaira H; Andoh K; Kasai T; Iwashita Y; Arai H; Murata M; Yamane M; Shiga K; Hori N
    Crit Care; 2017 Jul; 21(1):181. PubMed ID: 28701223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intravenous immunoglobulin for fulminant myocarditis on in-hospital mortality: propensity score analyses.
    Isogai T; Yasunaga H; Matsui H; Tanaka H; Horiguchi H; Fushimi K
    J Card Fail; 2015 May; 21(5):391-397. PubMed ID: 25639690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Intravenous Immunoglobulin on Survival in Necrotizing Fasciitis With Vasopressor-Dependent Shock: A Propensity Score-Matched Analysis From 130 US Hospitals.
    Kadri SS; Swihart BJ; Bonne SL; Hohmann SF; Hennessy LV; Louras P; Evans HL; Rhee C; Suffredini AF; Hooper DC; Follmann DA; Bulger EM; Danner RL
    Clin Infect Dis; 2017 Apr; 64(7):877-885. PubMed ID: 28034881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose corticosteroid use and mortality in severe community-acquired pneumonia patients.
    Tagami T; Matsui H; Horiguchi H; Fushimi K; Yasunaga H
    Eur Respir J; 2015 Feb; 45(2):463-72. PubMed ID: 25323232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sivelestat sodium and mortality in pneumonia patients requiring mechanical ventilation: propensity score analysis of a Japanese nationwide database.
    Kishimoto M; Yamana H; Inoue S; Noda T; Myojin T; Matsui H; Yasunaga H; Kawaguchi M; Imamura T
    J Anesth; 2017 Jun; 31(3):405-412. PubMed ID: 28243749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human soluble thrombomodulin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.
    Tagami T; Matsui H; Horiguchi H; Fushimi K; Yasunaga H
    J Thromb Haemost; 2015 Jan; 13(1):31-40. PubMed ID: 25393713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative polymyxin B hemoperfusion and mortality in patients with abdominal septic shock: a propensity-matched analysis.
    Iwagami M; Yasunaga H; Doi K; Horiguchi H; Fushimi K; Matsubara T; Yahagi N; Noiri E
    Crit Care Med; 2014 May; 42(5):1187-93. PubMed ID: 24365858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intravenous immunoglobulin on the outcome of children with septic shock in a PICU: a retrospective cohort study.
    Huang H; Chen J; Dang H; Liu C; Huo J; Fu YQ
    Eur J Pediatr; 2023 Dec; 182(12):5315-5323. PubMed ID: 37733114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study.
    Linnér A; Darenberg J; Sjölin J; Henriques-Normark B; Norrby-Teglund A
    Clin Infect Dis; 2014 Sep; 59(6):851-7. PubMed ID: 24928291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.
    Tagami T; Matsui H; Horiguchi H; Fushimi K; Yasunaga H
    J Thromb Haemost; 2014 Sep; 12(9):1470-9. PubMed ID: 24943516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis.
    Laupland KB; Kirkpatrick AW; Delaney A
    Crit Care Med; 2007 Dec; 35(12):2686-92. PubMed ID: 18074465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of low-dose intravenous immunoglobulin as the adjunctive therapy in septic shock patients with and without hypogammaglobulinemia: a retrospective cohort study.
    Goto K; Yasuda N; Sato Y
    Ann Palliat Med; 2022 Aug; 11(8):2600-2608. PubMed ID: 35695053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin for treating sepsis and septic shock.
    Alejandria MM; Lansang MA; Dans LF; Mantaring JB
    Cochrane Database Syst Rev; 2002; (1):CD001090. PubMed ID: 11869591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of polyclonal intravenous immunoglobulin in treating HIV-infected children with severe bacterial infections: a retrospective cohort study.
    Huang LC; Myer L; Jaspan HB
    BMC Infect Dis; 2008 Sep; 8():127. PubMed ID: 18811982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery.
    Buda S; Riefolo A; Biscione R; Goretti E; Cattabriga I; Grillone G; Bacchi-Reggiani L; Pacini D
    J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):440-5. PubMed ID: 16085247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin for treating sepsis and septic shock.
    Alejandria MM; Lansang MA; Dans LF; Mantaring JB
    Cochrane Database Syst Rev; 2001; (2):CD001090. PubMed ID: 11405973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.